HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Charlotte E Teunissen Selected Research
Charlotte E Teunissen Research Topics
Disease
166
Alzheimer Disease (Alzheimer's Disease)
11/2022 - 07/2004
90
Dementia (Dementias)
05/2022 - 01/2005
83
Cognitive Dysfunction
06/2022 - 01/2005
31
Disease Progression
01/2022 - 01/2005
29
Multiple Sclerosis
01/2022 - 01/2005
25
Atrophy
01/2022 - 01/2012
18
Frontotemporal Dementia (Semantic Dementia)
11/2022 - 07/2014
17
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2005
11
Parkinson Disease (Parkinson's Disease)
02/2022 - 01/2005
8
Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
10/2022 - 12/2015
8
Inflammation (Inflammations)
01/2022 - 09/2015
6
Amyloidosis
06/2022 - 03/2013
5
Neuroinflammatory Diseases
02/2022 - 01/2011
5
COVID-19
01/2022 - 01/2020
5
Relapsing-Remitting Multiple Sclerosis
11/2021 - 01/2013
5
Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/2020 - 01/2015
4
Nervous System Diseases (Neurological Disorders)
10/2021 - 01/2016
3
Cerebral Small Vessel Diseases
01/2022 - 07/2014
3
Genetic Risk Score
01/2021 - 11/2020
3
Neuromyelitis Optica (Devic's Disease)
01/2018 - 01/2011
2
Amyloid Plaque
11/2022 - 01/2018
2
Clinical Deterioration
12/2021 - 05/2021
2
Tauopathies
10/2021 - 11/2019
2
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
10/2021 - 01/2021
2
Polyneuropathies (Polyneuropathy)
10/2021 - 10/2021
2
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
03/2021 - 12/2018
2
Progressive Multifocal Leukoencephalopathy
01/2021 - 01/2019
2
Malnutrition (Nutritional Deficiencies)
01/2020 - 05/2019
2
Fatigue
01/2019 - 08/2013
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2019 - 12/2015
2
Hypoxia (Hypoxemia)
12/2018 - 09/2015
2
Chronic Progressive Multiple Sclerosis
11/2018 - 10/2018
2
Neoplasms (Cancer)
10/2018 - 01/2018
1
Paraproteinemias (Monoclonal Gammopathy)
07/2022
1
Monoclonal Gammopathy of Undetermined Significance
07/2022
1
Peripheral Nervous System Diseases (PNS Diseases)
07/2022
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
07/2022
1
Parkinsonian Disorders (Parkinsonism)
02/2022
1
Viral Meningitis
01/2022
Drug/Important Bio-Agent (IBA)
187
Biomarkers (Surrogate Marker)
IBA
11/2022 - 07/2004
86
Amyloid (Amyloid Fibrils)
IBA
11/2022 - 09/2010
36
Proteins (Proteins, Gene)
FDA Link
10/2022 - 01/2013
20
Apolipoproteins E (ApoE)
IBA
01/2022 - 01/2012
17
Amyloid beta-Peptides
IBA
01/2022 - 05/2013
10
Biological Products
IBA
05/2022 - 05/2012
10
Apolipoproteins
IBA
01/2020 - 01/2013
8
Enzymes
IBA
05/2020 - 05/2013
7
Glial Fibrillary Acidic Protein
IBA
01/2022 - 01/2020
7
Antibodies
IBA
01/2021 - 01/2005
6
Peptides (Polypeptides)
IBA
11/2022 - 01/2017
6
Threonine (L-Threonine)
FDA Link
11/2022 - 10/2012
6
Synucleins
IBA
02/2022 - 11/2018
6
Neurogranin
IBA
12/2021 - 10/2015
6
Immunosorbents
IBA
01/2019 - 05/2013
5
Natalizumab (Tysabri)
FDA Link
01/2022 - 01/2019
5
Cytokines
IBA
12/2021 - 04/2005
5
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 11/2016
5
Blood Proteins (Serum Proteins)
IBA
01/2021 - 01/2018
4
Proteome
IBA
01/2022 - 01/2013
4
Complement System Proteins (Complement)
IBA
01/2022 - 06/2012
3
Protein Glutamine gamma Glutamyltransferase 2
IBA
01/2021 - 12/2017
3
Protein Isoforms (Isoforms)
IBA
12/2020 - 01/2005
3
Homocysteine
IBA
10/2020 - 01/2005
3
Pemetrexed (MTA)
FDA Link
01/2020 - 01/2012
3
Pharmaceutical Preparations
IBA
11/2016 - 08/2012
2
tau Proteins (tau Protein)
IBA
11/2022 - 01/2020
2
Amino Acids
FDA Link
11/2022 - 01/2018
2
Protein Aggregates
IBA
10/2022 - 10/2018
2
ocrelizumab
IBA
01/2022 - 01/2021
2
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2022 - 12/2021
2
Chitinase-3-Like Protein 1
IBA
10/2021 - 09/2015
2
DNA (Deoxyribonucleic Acid)
IBA
10/2021 - 01/2014
2
HDL Lipoproteins
IBA
01/2021 - 10/2020
2
Gadolinium
IBA
01/2021 - 01/2020
2
amyloid beta-protein (1-42)
IBA
01/2021 - 07/2014
2
7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indole
IBA
11/2020 - 11/2020
2
Lipids
IBA
10/2020 - 07/2014
2
Folic Acid (Vitamin M)
FDA Link
Generic
10/2020 - 01/2017
2
Cholesterol
IBA
10/2020 - 01/2016
2
Apolipoprotein A-I (Apolipoprotein A1)
IBA
05/2020 - 01/2017
2
Uridine
IBA
01/2020 - 01/2017
2
Retinaldehyde (Retinal)
IBA
12/2019 - 11/2017
2
Biocompatible Materials (Biomaterials)
IBA
01/2019 - 12/2014
2
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2019 - 07/2016
2
glutaminyl-peptide cyclotransferase
IBA
10/2018 - 06/2017
2
Interleukin-6 (Interleukin 6)
IBA
11/2017 - 01/2017
2
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2015 - 01/2014
2
Antihypertensive Agents (Antihypertensives)
IBA
01/2015 - 01/2014
2
N-acetylaspartate (N-acetyl aspartate)
IBA
12/2014 - 05/2007
1
Apolipoprotein L1
IBA
10/2022
1
Immunoglobulin M (IgM)
IBA
07/2022
1
Paraproteins
IBA
07/2022
1
Myelin-Associated Glycoprotein
IBA
07/2022
1
Inflammasomes
IBA
02/2022
1
Dopamine (Intropin)
FDA Link
Generic
02/2022
1
1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
IBA
02/2022
1
C-Reactive Protein
IBA
01/2022
Therapy/Procedure
14
Therapeutics
07/2022 - 01/2005
2
Highly Active Antiretroviral Therapy (HAART)
01/2022 - 03/2016
2
Institutionalization (Institutionalized Persons)
01/2020 - 01/2020